On Monday, Shares of Interactive Brokers Group, Inc. (NASDAQ:IBKR), gained 5.68% to $42.43.
Interactive Brokers Group, stated its Electronic Brokerage monthly performance metrics for July.
Highlights for the month comprised of:
- 652 thousand Daily Average Revenue Trades (DARTs), 23% higher than preceding year and 9% higher than preceding month.
- Ending client equity of $65.8 billion, 23% higher than preceding year and flat to preceding month.
- Ending client margin loan balances of $18.1 billion, 14% higher than preceding year and 5% lower than preceding month.
- Ending client credit balances of $34.6 billion, 21% higher than preceding year and 3% higher than preceding month.
- 314 thousand client accounts, 18% higher than preceding year and 1% higher than preceding month.
- 476 annualized average cleared DARTs per client account.
Interactive Brokers Group, Inc. operates as an automated electronic broker and market maker in the United States and internationally. The company is involved in routing orders; and executing and processing trades in securities, futures, foreign exchange instruments, bonds, and mutual funds on about 100 electronic exchanges and trading venues.
Shares of Eversource Energy (NYSE:ES), inclined 0.26% to $49.85, during its last trading session.
Eversource Energy, stated earnings of $207.5 million, or $0.65 per share, in the second quarter of 2015, contrast with earnings of $127.4 million, or $0.40 per share, in the second quarter of 2014. Second quarter results comprised of after-tax integration costs of $2.1 million in 2015 and $4.5 million in 2014. Not taking into account those integration costs, Eversource Energy earned $209.6 million, or $0.66 per share1, in the second quarter of 2015 and $131.9 million, or $0.42 per share, in the second quarter of 2014.
In the first half of 2015, Eversource Energy earned $460.8 million, or $1.45 per share, contrast with earnings of $363.3 million, or $1.15 per share, in the first half of 2014. Not taking into account after-tax integration costs, Eversource Energy earned $466.9 million, or $1.47 per share1, in the first half of 2015, contrast with $373.7 million, or $1.18 per share1, in the first half of 2014.
Eversource Energy, a public utility holding company, through its auxiliaries, engages in the energy delivery business. The company operates in three segments: Electric Distribution, Electric Transmission, and Natural Gas Distribution.
At the end of Monday’s trade, Shares of ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), lost -1.77% to $53.96.
Isis Pharmaceuticals, declared that the FOCUS FH phase 3 study of KYNAMRO (mipomersen sodium) in patients with severe heterozygous familial hypercholesterolemia (severe HeFH) met its primary efficacy endpoint, a statistically noteworthyreduction in LDL-cholesterol after 60 weeks of treatment of once weekly injections of 200 mg of KYNAMRO contrast to placebo. LDL-cholesterol reduction was similar to that observed in previous phase 3 studies. In addition, based on the data accessible for review, the safety profile of KYNAMRO observed in the FOCUS FH trial was similar to the safety profile stated in previous phase 3 studies. Genzyme will provide a more in depth review of the safety and efficacy data at a future medical meeting.
“We are happy with the outcome of this fifth KYNAMRO randomized placebo controlled phase 3 trial, which shows statistically noteworthyreductions in LDL-cholesterol in severe HeFH,” said Richard Geary, Ph.D., senior vice president of development at Isis Pharmaceuticals. “It is encouraging to see sustained LDL-C reductions over 60 weeks that were similar to what we’ve observed in previous phase 3 studies and a safety profile compriseent with previous phase 3 and long-term extension studies. We look forward to the full analysis and presentation of this investigational data at an forthcoming scientific meeting.”
Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The companys flagship product comprises the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with homozygous familial hypercholesterolemia; and for the reduction of low-density lipoprotein cholesterol.
Finally, Penn West Petroleum Ltd (USA) (NYSE:PWE), ended its last trade with -8.15% loss, and closed at $1.24.
Penn West Petroleum Ltd, declared that the Board of Directors has declared a third quarter 2015 dividend of $0.01 per share to be paid on October 15, 2015 to shareholders of record at the close of business on September 30, 2015. Shareholders are advised that this dividend is designated as an “eligible dividend” for Canadian income tax purposes.
Penn West Petroleum Ltd. explores for, develops, and produces oil and natural gas properties in western Canada. The company’s properties are located in Alberta, British Columbia, Saskatchewan, Manitoba, and the Northwest Territories, Canada; and Wyoming, the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
